How to determine when SARS-CoV-2 antibody testing is or is not useful for 
population screening: A tutorial

Keller, Niklas; Jenny, Mirjam A.

doi:10.1177/2381468320963068

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

How to determine when SARS-CoV-2 antibody testing is or is not useful for population screening: A tutorial

MPS-Authors

/persons/resource/persons139567

Jenny, Mirjam A.
Center for Adaptive Rationality, Max Planck Institute for Human Development, Max Planck Society;
External Organizations;

External Resource

https://doi.org/10.1177%2F2381468320963068
(Publisher version)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

2381468320963068.pdf
(Publisher version), 2MB

Supplementary Material (public)

There is no public supplementary material available

Citation

Keller, N., & Jenny, M. A. (2020). How to determine when SARS-CoV-2 antibody testing is or is not useful for population screening: A tutorial. Medical Decision Making Policy & Practice, 5(2): 2381468320963068. doi:10.1177/2381468320963068.

Cite as: https://hdl.handle.net/21.11116/0000-0007-6B97-7

Abstract

There is no abstract available